Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Bishop-Bailey

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Circulation Research|February 2, 2008
Peroxisome proliferator-activated receptor beta/delta goes vascularDavid Bishop-Bailey
Steroids|September 26, 2009
The platelet as a model system for the acute actions of nuclear receptorsDavid Bishop-Bailey
Current Opinion in Pharmacology|December 6, 2008
Tumour vascularisation: a druggable targetDavid Bishop-Bailey
PPAR Research|April 3, 2008
A Role for PPARbeta/delta in Ocular AngiogenesisDavid Bishop-Bailey
Current Opinion in Investigational Drugs (London, England : 2000)|February 24, 2010
PPAR receptor activation: Experimental studies on cardiac structure and functionDavid Bishop-Bailey
Current Atherosclerosis Reports|March 17, 2015
Nuclear receptors in vascular biologyDavid Bishop-Bailey
Biochemical Society Transactions|November 23, 2011
PPARs and angiogenesisDavid Bishop-Bailey
Drug News & Perspectives|December 18, 2004
FXR as a novel therapeutic target for vascular diseaseDavid Bishop-Bailey
Experimental Physiology|September 18, 2007
Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biologyJessica Wray, David Bishop-Bailey
Prostaglandins & Other Lipid Mediators|May 17, 2003
Peroxisome proliferator-activated receptors: a critical review on endogenous pathways for ligand generationDavid Bishop-Bailey, Jessica Wray
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Circulation Research|February 2, 2008
Peroxisome proliferator-activated receptor beta/delta goes vascularDavid Bishop-Bailey
Steroids|September 26, 2009
The platelet as a model system for the acute actions of nuclear receptorsDavid Bishop-Bailey
Current Opinion in Pharmacology|December 6, 2008
Tumour vascularisation: a druggable targetDavid Bishop-Bailey
PPAR Research|April 3, 2008
A Role for PPARbeta/delta in Ocular AngiogenesisDavid Bishop-Bailey
Current Opinion in Investigational Drugs (London, England : 2000)|February 24, 2010
PPAR receptor activation: Experimental studies on cardiac structure and functionDavid Bishop-Bailey
Current Atherosclerosis Reports|March 17, 2015
Nuclear receptors in vascular biologyDavid Bishop-Bailey
Biochemical Society Transactions|November 23, 2011
PPARs and angiogenesisDavid Bishop-Bailey
Drug News & Perspectives|December 18, 2004
FXR as a novel therapeutic target for vascular diseaseDavid Bishop-Bailey
Experimental Physiology|September 18, 2007
Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biologyJessica Wray, David Bishop-Bailey
Prostaglandins & Other Lipid Mediators|May 17, 2003
Peroxisome proliferator-activated receptors: a critical review on endogenous pathways for ligand generationDavid Bishop-Bailey, Jessica Wray
Pageof 7